CuriRx Embraces Collaboration Opportunities at Bioprocessing International Conference 2023

CuriRx Launches the Advanced Bioprocessing and Analytical Center to Support Biotherapeutic Drug Developers
Visit CuriRx at Booth 250 in Bioprocessing International Conference 2023

Visit CuriRx at Booth 250 in Bioprocessing International Conference 2023

WILMINGTON, MA, September 12, 2023—

CuriRx, a pioneering Contract Research, Development, and Manufacturing Organization (CRDMO) based in Massachusetts, is thrilled to announce its participation in the upcoming Bioprocessing International Conference(BPI) at the Boston Convention and Exhibition Center from September 18-21. The event, renowned as the largest gathering in the bioprocessing industry, provides an exceptional platform for professionals to accelerate the journey of promising biologics, cell therapies, and gene therapies toward commercial success. CuriRx welcomes any attendees of this event to visit booth 250.

CuriRx has solidified its position as a leader in the bioprocessing sector, boasting advanced expertise and a proven track record in delivering cutting-edge solutions. The Bioprocessing International Conference, scheduled to be held in Boston, presents an exciting opportunity for CuriRx to showcase its commitment to innovation and excellence. 

At the conference, CuriRx aims to elevate its brand presence and foster meaningful connections within the industry. As a distinguished CRDMO, the company is primed to engage with fellow experts, thought leaders, and potential clients seeking innovative solutions in bioprocessing, formulation development, and analytical services. The event’s dynamic environment provides a conducive setting for CuriRx to explore new collaborations, exchange insights, and discuss the latest advancements in the field. 

“Our participation in the Bioprocessing International Conference underscores our dedication to shaping the future of bioprocessing,” said PhD. Indu Javeri, President, and CEO at CuriRx. “We are excited to engage with peers and prospective clients, sharing our insights and exploring avenues for transformative partnerships. Our goal is to contribute to the advancement of biologics, cell therapies, and gene therapies through our expertise.” 

CuriRx‘s presence at the conference will spotlight its comprehensive capabilities in product development, from DNA to ready-to-fill bulk drugs. With a deep commitment to accelerating the commercial success of groundbreaking therapies, CuriRx is poised to make a significant impact at the event. 

For those interested in meeting with CuriRx during the conference, the company welcomes the opportunity to connect, share insights, and explore collaborations that contribute to advancing bioprocessing technologies. Schedule a meeting with CuriRx via BPI ConnectMe, either the desktop site or the ConnectMe app version. You could also reach out to CuriRx via email at, or via phone at 978-658-2962. We look forward to hearing from you.

About CuriRx: CuriRx is a leading Contract Research, Development and Manufacturing Organization based in Massachusetts, consisting of a minority female entrepreneur and a group of experts with diverse backgrounds. The company specializes in bioprocessing, formulation, and analytical services. With a commitment to innovation, quality, and client success, CuriRx is at the forefront of transforming scientific breakthroughs into commercial realities. 

For more information about the Bioprocessing International Conference, please visit